Omnicell (OMCL) announced the opening of its Innovation Lab in Austin, Texas. The facility will serve as a hub focused on addressing challenges along the medication and supply journey and developing new technologies. Omnicell’s team will focus on developing concepts and quickly testing feasibility through an “innovation sprint” model. Technologies planned for development include robotics, AI, autonomous devices, sensor technologies, and machine vision.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell upgraded to Overweight from Equal Weight at Wells Fargo
- Positive Outlook for Omnicell: Strong Demand and Market Stability Drive Buy Rating
- Omnicell price target lowered to $53 from $64 at Craig-Hallum
- Omnicell price target lowered to $30 from $37 at BofA
- Omnicell price target lowered to $40 from $62 at Benchmark